Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.
about
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropeniacontinuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysisAmphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia.Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings.Antifungal pharmacokinetics and pharmacodynamicsRecent advances in antifungal pharmacotherapy for invasive fungal infections.New developments in antifungal strategy.Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsLiposomal amphotericin B: clinical experience and perspectives.Emerging echinocandins for treatment of invasive fungal infections.Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients.Invasive fungal infections and antifungal therapies in solid organ transplant recipients.Current options in antifungal pharmacotherapy.Nephrotoxicity in the setting of invasive fungal diseases.Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer.Invasive aspergillosis in near drowning nonneutropenic patient.Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micellesIn vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine.Update on antifungal treatment of invasive Candida and Aspergillus infections.Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.Amphotericin B deoxycholate: time to retire our old standard?Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections.
P2860
Q24193811-EDEC5064-8024-49B3-8738-6D6E4ACAB981Q28534551-6F96B78C-84F0-40CE-8504-DACB21285D0BQ30887348-176AA829-E84C-46F7-BF23-48DC28C5A883Q33876645-F88D8D01-A54C-4AE9-B799-0CCD318D8806Q34801921-18B757C9-1EA2-43F7-9C92-32FF8747BFA5Q35663841-AF39BF0D-2AC7-4FAB-A663-E78271709BADQ35917383-A4898767-13BB-4021-A7A7-30CADECAD0F5Q35917388-595E0429-2C29-48F8-9348-6BE5EE1E2C7CQ36087577-688D6D52-31F9-49A7-8F76-1BD4E6B8B5CAQ36140647-A5CF67A0-8EE8-4EB8-BC03-58694AAFC108Q36458402-90033893-EB15-4517-8608-876340059633Q36613885-036FF1E7-F17F-415F-8FBC-37B32AF146F2Q36872848-EBB9AF3F-BB57-4AC0-A3D3-15349523303EQ37151326-35A25EE6-EE8C-4A90-A575-58506EEFA301Q37159573-B572B91C-FDA7-46C0-B603-4BBB59940450Q37873552-2DF2E1EA-5EB4-4E46-AC43-43C56E4711A1Q38040820-C6610E66-A075-4072-8FEC-902245AB85C6Q38193337-F32C9857-DC00-48C2-88D4-4010BD1B9435Q40031682-8B2F83DF-6417-4806-83FB-A1999BF08173Q40816127-013F2F28-C5C1-41A4-9BF2-6BC75AEE643BQ41915894-953E9BA0-84E7-4410-BBB4-5CE6DA28E276Q42676999-6E6CAB71-AB42-48DF-9FDA-FBC4973065EFQ43102684-382AEF49-63C1-4BD0-A462-4A6BB46A166EQ45017863-FFE6319B-6AE4-4546-8B20-F7AD474A624DQ46373110-75932193-D6B1-4981-8347-1E79147D69C5Q46545423-AD37A0FE-1DFB-4607-BD2D-B2DFB72346ABQ47141618-F3F1F5FA-B8E9-4272-9098-F0490E3EBB16
P2860
Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Continuous infusion of escalat ...... pen-label observational study.
@en
Continuous infusion of escalat ...... pen-label observational study.
@nl
type
label
Continuous infusion of escalat ...... pen-label observational study.
@en
Continuous infusion of escalat ...... pen-label observational study.
@nl
prefLabel
Continuous infusion of escalat ...... pen-label observational study.
@en
Continuous infusion of escalat ...... pen-label observational study.
@nl
P2860
P356
P1476
Continuous infusion of escalat ...... pen-label observational study.
@en
P2093
Alexander Imhof
Andreas Schaffner
P2860
P304
P356
10.1086/368312
P407
P577
2003-04-04T00:00:00Z